Hyundai Pharm (004310) — Capital Reinvestment Ratio
Hyundai Pharm (004310) has a Capital Reinvestment Ratio of 0.46x as of May 2026, meaning it reinvests 0% of its operating cash flow (₩2.39 Billion) in capital expenditures (₩1.09 Billion). Check Hyundai Pharm (004310) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hyundai Pharm Capital Reinvestment Ratio (2010–2022)
This chart tracks Hyundai Pharm's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Hyundai Pharm (004310) cash conversion ratio.
Annual Capital Reinvestment Ratio for Hyundai Pharm (2010–2022)
Year-by-year Capital Reinvestment Ratio for Hyundai Pharm from 2010 to 2022. See 004310 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.57x | ₩11.62 Billion | ₩6.58 Billion | ▼ -57.3% |
| 2021 | 1.33x | ₩5.13 Billion | ₩6.81 Billion | ▲ +123.9% |
| 2020 | 0.59x | ₩10.80 Billion | ₩6.40 Billion | ▲ +74.8% |
| 2019 | 0.34x | ₩6.96 Billion | ₩2.36 Billion | ▼ -64.0% |
| 2018 | 0.94x | ₩2.83 Billion | ₩2.67 Billion | ▲ +233.7% |
| 2013 | 0.28x | ₩7.95 Billion | ₩2.24 Billion | ▼ -52.0% |
| 2011 | 0.59x | ₩6.27 Billion | ₩3.68 Billion | ▼ -60.1% |
| 2010 | 1.47x | ₩2.68 Billion | ₩3.95 Billion | — |